Assignee
BIONTECH RNA PHARMACEUTICALS GMBH
DE·21 granted patents·9 pending applications·91 citations·filing 2013–2021
Top patents by PatentIndex Score
30 records- 0197US10808242B2Method for reducing immunogenicity of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 20, 2020·11 cites·7 claims
- 0293US10717982B2Stabilization of poly(A) sequence encoding DNA sequencesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Jul 21, 2020·18 cites·19 claims
- 0391US10576146B2Particles comprising a shell with RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Mar 3, 2020·13 cites·15 claims
- 0490US10155031B2Individualized vaccines for cancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 18, 2018·12 cites·19 claims
- 0589US10485884B2RNA formulation for immunotherapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Nov 26, 2019·16 cites·39 claims
- 0687US11045418B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Jun 29, 2021·3 cites·8 claims
- 0787US10669322B2RNA molecules encoding cytokine fusion proteins and methods of use thereofBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Jun 2, 2020·4 cites·28 claims
- 0886US11173120B2Stable formulations of lipids and liposomesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 16, 2021·4 cites·54 claims
- 0982US11156617B2Predicting T cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 26, 2021·3 cites·21 claims
- 1079US10301368B2Cytokine fusion proteinsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted May 28, 2019·4 cites·22 claims
- 1178US11471522B2Methods and compositions for stimulating immune responseBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Oct 18, 2022·1 cites·30 claims
- 1277US11318195B2Formulation for administration of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 1376US11168337B2RNA replicon for versatile and efficient gene expressionBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted Nov 9, 2021·1 cites·23 claims
- 1473US11337922B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Granted May 24, 2022·0 cites·17 claims
- 1560US12281138B25′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Apr 22, 2025·0 cites·69 claims
- 1660US2022074948A1Predicting t cell epitopes useful for vaccinationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1759US2021340170A15'-cap compounds and their uses in stabilizing rna, expressing proteins and in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 1858US11920194B2Methods for characterizing loss of antigen presentationBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Mar 5, 2024·0 cites·23 claims
- 1952US10808019B2Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligandsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Oct 20, 2020·0 cites·21 claims
- 2052US2022062439A1Localized administration of rna molecules for therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 2151US11020477B2RNA vaccinesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted Jun 1, 2021·0 cites·14 claims
- 2248US12522640B2IL2 agonistsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Jan 13, 2026·0 cites·25 claims
- 2347US2019153425A1Methods for Providing Single-Stranded RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 2447US2021290746A1Individualized Vaccines for CancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2546US12291717B2RNA replicon for reprogramming somatic cellsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted May 6, 2025·0 cites·19 claims
- 2645US2021113606A1Treatment using cytokine encoding rnaBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2743US2020362313A1Method of enhancing rna expression in a cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 2842US2019189241A1Selecting Neoepitopes as Disease-Specific Targets for Therapy with Enhanced EfficacyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 2942US2020191798A1Dose determination for immunotherapeutic agentsBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 3030US10429392B2Methods and compositions for diagnosis and treatment of cancerBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →